Скачать с ютуб Human trial suggests NMN might benefit people | Longevity Science News в хорошем качестве

Human trial suggests NMN might benefit people | Longevity Science News

A new human trial suggests that nicotinamide mononucleotide may be beneficial for prediabetic patients; an FDA-approved drug is a potential candidate to treat dry age-related macular degeneration; the Chinese practice of qigong seems to attenuate cognitive decline in aging. We'll talk about these stories and more in this episode of Longevity Science News. CHAPTERS ⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺ 0:00 Intro 0:26 NMN Human Trial Suggests Improved Muscle Glucose Metabolism 1:53 BioAge Off to a Rapid Start in 202lifespan 3:15 FDA-Approved Drug Is a Candidate for Dry AMD Treatment 4:43 No Evidence of Physiological Decline With Age in an Extremely Long-Lived Fish 6:08 Qigong Attenuates Age-Related Cognitive Decline in Trial Check out the latest video by ‪@TheSheekeyScienceShow‬:    • Could hypoxia reduce the SASP?   Check out the latest video by Science to Save the World:    • Could Science Slow Down Aging In Dogs...   SOURCES AND FURTHER READING ⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺ No Evidence of Physiological Decline With Age in an Extremely Long-Lived Fish: https://www.nature.com/articles/s4159... FOOTAGE, IMAGES, AND MUSIC CREDITS ⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺ Stock photos: Shutterstock.com Stock footage: Videoblocks.com Music: "Retro 80s technology" by Eric Matyas Thumbnail font: Cocogoose Pro Family by Zetafonts -http://www.zetafonts.com/collection/308 Other sources: https://www.nature.com/articles/s4159... https://science.sciencemag.org/conten... https://www.aging-us.com/article/2029... https://www.sciencedirect.com/science... https://bioagelabs.com/ “Bigmouth Buffalo” by Alus164 is licensed under CC BY-SA 4.0 ⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺ #qigong #nmn #clinicaltrials #maculardegeneration #bioage #aging #longevity